NIM
PFE icon

Northeast Investment Management’s Pfizer PFE Stock Holding History

Northeast Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$930K Buy
38,632
+600
+2% +$15.7K 0.03% 119
2026
Q1 		$1.07M Sell
38,032
-29
-0.1% -$772 0.04% 110
2025
Q4 		$948K Sell
38,061
-1,136
-3% -$28.6K 0.04% 114
2025
Q3 		$999K Sell
39,197
-5,454
-12% -$135K 0.04% 108
2025
Q2 		$1.08M Sell
44,651
-10,406
-19% -$243K 0.05% 106
2025
Q1 		$1.4M Sell
55,057
-8,549
-13% -$224K 0.07% 95
2024
Q4 		$1.69M Sell
63,606
-36,493
-36% -$990K 0.07% 87
2024
Q3 		$2.9M Sell
100,099
-5,459
-5% -$159K 0.13% 75
2024
Q2 		$2.95M Sell
105,558
-24,807
-19% -$683K 0.14% 72
2024
Q1 		$3.62M Sell
130,365
-40,120
-24% -$1.11M 0.18% 71
2023
Q4 		$4.91M Sell
170,485
-86,745
-34% -$2.62M 0.26% 65
2023
Q3 		$8.53M Sell
257,230
-17,445
-6% -$617K 0.5% 48
2023
Q2 		$10.1M Sell
274,675
-8,280
-3% -$322K 0.57% 47
2023
Q1 		$11.5M Sell
282,955
-1,111
-0.4% -$48K 0.7% 44
2022
Q4 		$14.6M Sell
284,066
-5,578
-2% -$267K 0.93% 37
2022
Q3 		$12.7M Sell
289,644
-29,793
-9% -$1.45M 0.86% 39
2022
Q2 		$16.7M Buy
319,437
+18,196
+6% +$927K 1.07% 29
2022
Q1 		$15.6M Buy
301,241
+9,490
+3% +$492K 0.82% 36
2021
Q4 		$17.2M Buy
291,751
+45,214
+18% +$2.24M 0.84% 37
2021
Q3 		$10.6M Buy
246,537
+17,350
+8% +$769K 0.57% 42
2021
Q2 		$8.97M Buy
229,187
+58,342
+34% +$2.27M 0.48% 46
2021
Q1 		$6.19M Buy
170,845
+2,985
+2% +$106K 0.37% 53
2020
Q4 		$6.18M Sell
167,860
-5,685
-3% -$209K 0.38% 53
2020
Q3 		$6.04M Buy
173,545
+19,467
+13% +$683K 0.4% 51
2020
Q2 		$4.78M Sell
154,078
-1,224
-0.8% -$41.6K 0.36% 56
2020
Q1 		$4.81M Buy
155,302
+371
+0.2% +$12.6K 0.44% 56
2019
Q4 		$5.76M Sell
154,931
-1,433
-0.9% -$51K 0.42% 60
2019
Q3 		$5.33M Sell
156,364
-2,033
-1% -$73.9K 0.43% 56
2019
Q2 		$6.51M Buy
158,397
+6,021
+4% +$239K 0.52% 51
2019
Q1 		$6.14M Sell
152,376
-4,014
-3% -$161K 0.52% 50
2018
Q4 		$6.48M Buy
156,390
+1,226
+0.8% +$50.9K 0.62% 45
2018
Q3 		$6.49M Sell
155,164
-903
-0.6% -$34.8K 0.52% 50
2018
Q2 		$5.37M Buy
156,067
+925
+0.6% +$31.6K 0.45% 57
2018
Q1 		$5.22M Sell
155,142
-3,966
-2% -$136K 0.46% 61
2017
Q4 		$5.47M Sell
159,108
-747
-0.5% -$25.5K 0.46% 62
2017
Q3 		$5.41M Buy
159,855
+2,117
+1% +$68K 0.48% 59
2017
Q2 		$5.03M Sell
157,738
-1,258
-0.8% -$39.7K 0.46% 60
2017
Q1 		$5.16M Sell
158,996
-182
-0.1% -$5.74K 0.48% 59
2016
Q4 		$4.91M Buy
159,178
+1,234
+0.8% +$37.7K 0.47% 61
2016
Q3 		$5.08M Buy
157,944
+10,113
+7% +$338K 0.51% 60
2016
Q2 		$4.94M Buy
147,831
+449
+0.3% +$14.3K 0.5% 57
2016
Q1 		$4.14M Buy
147,382
+2,608
+2% +$74.5K 0.43% 62
2015
Q4 		$4.43M Sell
144,774
-1,850
-1% -$58.2K 0.46% 61
2015
Q3 		$4.37M Buy
146,624
+5,153
+4% +$165K 0.47% 61
2015
Q2 		$4.5M Buy
141,471
+1,191
+0.8% +$38.8K 0.45% 60
2015
Q1 		$4.63M Buy
140,280
+950
+0.7% +$30.2K 0.45% 59
2014
Q4 		$4.12M Buy
139,330
+1,508
+1% +$43.2K 0.4% 62
2014
Q3 		$3.87M Buy
137,822
+1,465
+1% +$41.1K 0.39% 65
2014
Q2 		$3.84M Buy
136,357
+4,572
+3% +$130K 0.39% 64
2014
Q1 		$4.02M Sell
131,785
-1,168
-0.9% -$34.8K 0.43% 64
2013
Q4 		$3.86M Buy
132,953
+4,361
+3% +$127K 0.43% 61
2013
Q3 		$3.5M Buy
128,592
+5,870
+5% +$160K 0.43% 62
2013
Q2 		$3.26M Buy
+122,722
New +$3.39M 0.42% 62

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Northeast Investment Management's PFE Position: Q2 2026 in Review

Northeast Investment Management increased its Pfizer (PFE) stake by 1.6% in Q2 2026, buying an estimated $15.7K and bringing the position to 38,632 shares worth $930K. The position accounts for 0.03% of the portfolio, ranked #119.

Northeast Investment Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $17.2M in Q4 2021. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Northeast Investment Management held 38,632 shares of Pfizer worth $930K as of Q2 2026.
  • Northeast Investment Management bought 600 Pfizer shares in Q2 2026, an estimated $15.7K.
  • Pfizer made up 0.03% of Northeast Investment Management's portfolio in Q2 2026, its #119 holding.
  • Northeast Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Northeast Investment Management's Pfizer position peaked at $17.2M in Q4 2021.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Northeast Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.